Why Deaf People Oppose Using Gene Editing to "Cure" Deafness
By Sarah Katz,
Discover
| 08. 11. 2020
Researchers have figured out how to use a gene-editing tool called CRISPR 2.0 to prevent and treat deafness. But many deaf people are happy the way they are.
Deaf Power Poster
As someone who was born deaf, I’m concerned about the latest application of a gene-editing tool called CRISPR 2.0. And I'm not alone. In June, researchers at Boston Children's Hospital, Harvard and MIT announced that, using mice, they figured out how to use the technology to temporarily “correct” a mutation in the TMC1 gene, which can cause deafness in babies. The work is a monumental step toward reversing hereditary deafness in people with a single injection. It could drastically change the fact that two to three out of every 1,000 U.S. children are born deaf or hard of hearing, according to research completed in 2007.
CRISPR 2.0 is a more precise version of the gene-editing tool CRISPR-Cas9, which works like a pair of molecular scissors. Scientists use it to cut strands of DNA. These scissors are built from the defense mechanisms of bacteria, which chop up and destroy the DNA of viruses to prevent their invasion. And in this recent study, they were able to use the smaller scissors of CRISPR 2.0 created in 2017 — think tweezers...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...